NCT02502721

A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

A Randomized, Open-labeled, Oral Dose, Crossover Design Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 58 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-labeled, oral dose, crossover design clinical trial to evaluate pharmacokinetics and safety between DWC20151 and DWC20152 in healthy male subjects.

Detailed description

This study is to evaluate pharmacokinetics and safety between DWC20151 and DWC20152 in healthy male subjects. Study design is randomized, open-labeled, oral dose, crossover design. This study will conducted with 2 separated part (Part A, Part B).

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DWC20151
DRUG	DWC20152

Timeline

• Start date: 2015-06-01
• Primary completion: 2015-07-01
• Completion: 2015-08-01
• First posted: 2015-07-20
• Last updated: 2015-08-25

Locations

1 site across 1 country: South Korea